Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy


ISSN: 1177-8881

Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Journal Impact Factor: 3.216 (5 year impact 3.270)

 

 

  

 

Indexed online:

 

  • PubMed and PubMed Central (Drug Des Devel Ther)
  • MedLine on MEDLARs
  • Science Citation Index Expanded (also known as SciSearch®)
  • Journal Citation Reports/Science Edition
  • Biological Abstracts
  • BIOSIS Previews
  • Embase, from 2009 (Correct as at December 8, 2016)
  • Scopus, from 2009 (Correct as at December 8, 2016)
  • Directory of Open Access Journals (DOAJ)
  • OAIster: The Open Access Initiative

Latest articles:

- 5 records -

Alendronate Alleviated Femoral Head Necrosis and Upregulated BMP2/EIF2AK3/EIF2A/ATF4 Pathway in Liquid Nitrogen Treated Rats

Rong K, Li X, Jiang W, Wu X, Xia Q, Chen J, Yin X

Drug Design, Development and Therapy 2021, 15:1717-1724

Published Date: 23 April 2021

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians

Kanokrungsee S, Anuntrangsee T, Tankunakorn J, Srisuwanwattana P, Suchonwanit P, Chanprapaph K

Drug Design, Development and Therapy 2021, 15:1677-1690

Published Date: 22 April 2021

Lactobacillus plantarum ZS62 Alleviates Alcohol-Induced Gastric Injury in Mice via an Anti-Oxidative Mechanism

Wu Y, Hu J, Long X, Pan Y, Mu J, Park KY, Zhao X

Drug Design, Development and Therapy 2021, 15:1667-1676

Published Date: 22 April 2021

 

Read more articles